ATE188871T1 - Verfahren zur behandlung von viralen infectionen - Google Patents

Verfahren zur behandlung von viralen infectionen

Info

Publication number
ATE188871T1
ATE188871T1 AT93914168T AT93914168T ATE188871T1 AT E188871 T1 ATE188871 T1 AT E188871T1 AT 93914168 T AT93914168 T AT 93914168T AT 93914168 T AT93914168 T AT 93914168T AT E188871 T1 ATE188871 T1 AT E188871T1
Authority
AT
Austria
Prior art keywords
image
treating viral
aliphatic
viral infections
phenylacetylglutamine
Prior art date
Application number
AT93914168T
Other languages
English (en)
Inventor
Stanislaw R Burzynski
Original Assignee
Stanislaw R Burzynski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanislaw R Burzynski filed Critical Stanislaw R Burzynski
Application granted granted Critical
Publication of ATE188871T1 publication Critical patent/ATE188871T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT93914168T 1992-05-27 1993-05-26 Verfahren zur behandlung von viralen infectionen ATE188871T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/888,976 US5244922A (en) 1990-09-04 1992-05-27 Methods for treating viral infections
PCT/US1993/005002 WO1993024123A1 (en) 1992-05-27 1993-05-26 Methods for treating viral infections

Publications (1)

Publication Number Publication Date
ATE188871T1 true ATE188871T1 (de) 2000-02-15

Family

ID=25394288

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93914168T ATE188871T1 (de) 1992-05-27 1993-05-26 Verfahren zur behandlung von viralen infectionen

Country Status (8)

Country Link
US (1) US5244922A (de)
EP (1) EP0601164B1 (de)
AT (1) ATE188871T1 (de)
AU (1) AU4392793A (de)
DE (1) DE69327642T2 (de)
ES (1) ES2142873T3 (de)
SG (1) SG67344A1 (de)
WO (1) WO1993024123A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0527241B1 (de) * 1991-07-15 1994-03-16 Artesan Pharma Gesellschaft mit beschränkter Haftung Verwendung der Ascorbinsäure zur Zubereitung von Arzneimitteln zur Anwendung im Genitalbereich
US5635532A (en) * 1991-10-21 1997-06-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
WO1993014197A1 (en) * 1992-01-16 1993-07-22 New York University Hypericin treatment of vaccine agents for improved immunogenicity
US5646182A (en) * 1992-06-15 1997-07-08 Burzynski; Stanislaw R. Methods for treating autoimmune diseases
US5391575A (en) * 1994-05-04 1995-02-21 Burzynski; Stanislaw R. Method for treating neurofibromatosis
US5654335A (en) * 1996-02-23 1997-08-05 University Of Iowa Research Foundation Topical use of ethyl ethacrynate for glaucoma treatment
US5565434A (en) * 1996-02-23 1996-10-15 University Of Iowa Research Foundation Hexose and pentose prodrugs of ethacrynic acid
WO1997042939A1 (en) * 1996-05-14 1997-11-20 Burzynski Research Inst Liposomal antineoplaston therapies with markedly improved antineoplastic activity
US5932618A (en) * 1996-11-04 1999-08-03 Signal Pharmaceuticals, Inc. Anti-viral agents and methods relating to the use thereof
US6258849B1 (en) * 1998-07-23 2001-07-10 Stanislaw R. Burzynski Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate
EP1642885B1 (de) 2000-08-29 2009-11-11 Biocon Limited Verwendung einer pharmazeutischen Zusammensetzung mit einem Para-Aminophenylessigsäurederivat für die Behandlung von entzündlichen Erkrankungen des Magen-Darmtrakts
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US6495719B2 (en) 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7842727B2 (en) 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
WO2003099272A1 (en) 2002-05-22 2003-12-04 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
JP2006508986A (ja) * 2002-11-20 2006-03-16 エルラント ゲネ セラペウチクス エルエルシー ヒストンデアセチラーゼ阻害剤による肺細胞の治療方法
RU2221562C1 (ru) * 2002-12-23 2004-01-20 Сибирский государственный медицинский университет Лекарственное средство и способ лечения генитального остроконечного кондиломатоза
US20060246016A1 (en) * 2003-05-28 2006-11-02 Burzynski Stanislaw R Toothpaste containing anticancer agents
RU2234313C1 (ru) * 2003-06-04 2004-08-20 Кривошеин Юрий Семенович Средство инактивации коронавирусов
HUE028158T2 (en) 2004-07-07 2016-12-28 Biocon Ltd Synthesis of bound immunoregulatory compounds
EP1817020A4 (de) * 2004-11-08 2012-11-21 Errant Gene Therapeutics Inc Inhibitoren der histondeacetylase
WO2013062028A1 (ja) * 2011-10-25 2013-05-02 塩野義製薬株式会社 Ｈｉｖ複製阻害剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK315482A (da) * 1981-07-20 1983-01-21 Kimberly Clark Co Fremgangsmaade til hindring af spredning af aandedraetsvira og middel til anvendelse ved fremgangsmaaden
US4558057A (en) * 1981-12-15 1985-12-10 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease
US4427684A (en) * 1982-09-24 1984-01-24 Ores Richard O Treatment and prevention of infection with herpes simplex and related viruses
DE3650733T2 (de) * 1985-09-11 2000-05-04 Btg International Ltd., London Pharmazeutische Zubereitungen und medizinische Verwendungen von Dioxopiperidinderivaten, insbesondere als Verstärker der Immunantwort sowie als antivirale und antibakterielle Wirkstoffe
US4705796A (en) * 1986-08-25 1987-11-10 Stereochemical Genetics, Inc. Use of 3-N-phenylacetylamino-2,6-piperidinedione for treatment of neuropsychiatric disorders
DE3814549A1 (de) * 1987-10-30 1989-05-18 Bayer Ag N-substituierte derivate von 1-desoxynojirimycin und 1-desoxymannonojirimycin, verfahren zu deren herstellung und deren verwendung in arzneimitteln
US5110600A (en) * 1988-01-25 1992-05-05 The Regents Of The University Of California Method of treating viral infections with amino acid analogs
US5089508A (en) * 1990-09-04 1992-02-18 Burzynski Stanislaw R Methods for treating aids

Also Published As

Publication number Publication date
ES2142873T3 (es) 2000-05-01
WO1993024123A1 (en) 1993-12-09
EP0601164B1 (de) 2000-01-19
DE69327642T2 (de) 2000-06-08
AU4392793A (en) 1993-12-30
DE69327642D1 (de) 2000-02-24
EP0601164A1 (de) 1994-06-15
US5244922A (en) 1993-09-14
HK1014499A1 (en) 1999-09-30
SG67344A1 (en) 1999-09-21
EP0601164A4 (de) 1994-10-26

Similar Documents

Publication Publication Date Title
DE69327642D1 (de) Verfahren zur behandlung von viralen infectionen
ES2189874T3 (es) Dinucleotidos utiles para el tratamiento de enfermedades pulmonares.
NO20073151L (no) Fremgangsmater og sammensetninger for a behandle hepatitt C virus
RU95110698A (ru) Способ лечения инфекций, вызываемых вирусом гепатита в
EP0786458A3 (de) Derivate und analoge der 2-Deoxy-2,3-didehydro-N-acetyl-Neuraminsäure und ihre Verwendung als antivirale Agentien
RU97116714A (ru) Композиция селективных ингибиторов вирусных или бактериальных нейраминидаз (варианты), способ лечения или профилактики заболевания гриппом, способ лечения или профилактики вирусных заболевания (варианты)
UA40589C2 (uk) Спосіб лікування людини, що страждає від вірусної інфекції, фармацевтична композиція, комбінація речовин для отримання ліків та фармацевтична комбінація
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
RU94002475A (ru) Фармацевтическая композиция и ее применение для лечения вирусных инфекций
DE69727956D1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
ATE157252T1 (de) 3'-azido-2',3'-dideoxy-5-methylcytidin enthaltende antivirale zusammensetzungen
ATE2622T1 (de) 2-niedrigalkyl-7-substituierte-2 oder 3-cephem-4- carbonsaeuren, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
PT100415A (pt) Novas morfolinas de accao farmaceutica, e processo para a sua preparacao
DE2509531A1 (de) Antivirales mittel
KR900001697A (ko) 치료용 화합물
KR900701278A (ko) 바이러스 감염 치료용 담즙산
ATE162714T1 (de) Zusammensetzungen und verfahren zur behandlung von autoimmunkrankheiten
ATE135217T1 (de) Pharmazeutische zusammensetzungen zur aids- behandlung
US5314689A (en) Acyl-carnitine for the treatment and prevention of viral infections
KR960703924A (ko) 항바이러스제로서 신규한 벤조티오펜 유사체(Novel Benzothiophene Analogs as Antiviral Agents)
ES2005778A6 (es) Procedimiento para la obtencion de derivados de diisobutilxantina.
DE59105323D1 (de) Neue Salze der 2-(2,6-Dichloranilino)-phenylessigsäure, Verfahren zu ihrer Herstellung und ihre Verwendung für topisch anwendbare pharmazeutische Zubereitungen.
RU98103770A (ru) 2-амино-9-(3-гидроксиметил-4-алкоксикарбонилоксибут-1-ил)пурина и фармацевтическая композиция, содержащая его
RU2001134133A (ru) Использование аминопуриновых противовирусных соединений для лечения и профилактики латентных инфекций, вызванных вирусом герпеса
DK0674645T3 (da) Cephemforbindelser med antimikrobiel virkning

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties